Psyadon Healthcares

Developer of medicinal drugs intended to be used for treating psychiatric and neurodegenerative diseases. The company's medicinal drugs are focused on discovering, developing and marketing drugs, Ecopipam which selectively blocks the actions of the neurotransmitter dopamine at the D1 subtype in the brain, enabling targeted patients to help them get a cure who previously have no other therapeutic options.

New Enterprise Associates

🏥 Healthcare